Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-11.83M
↓ 98% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-5.98M
Historical baseline
PeriodValueYoY Change
TTM$-11.83M-60.7%
2024$-7.36M-108.4%
2023$-3.53M-193.3%
2022$-1.20M-